157 related articles for article (PubMed ID: 7913003)
1. Adaptive changes in rat striatal preproenkephalin expression and dopamine-opioid interactions upon chronic haloperidol treatment during different developmental stages.
De Vries TJ; Jonker AJ; Voorn P; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1994 Apr; 78(2):175-81. PubMed ID: 7913003
[TBL] [Abstract][Full Text] [Related]
2. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
[TBL] [Abstract][Full Text] [Related]
5. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
Chen JF; Aloyo VJ; Weiss B
Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
[TBL] [Abstract][Full Text] [Related]
6. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
7. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
8. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of glutamate decarboxylase and preproenkephalin mRNA levels in the rat striatum.
Soghomonian JJ
Brain Res; 1994 Mar; 640(1-2):146-54. PubMed ID: 8004444
[TBL] [Abstract][Full Text] [Related]
10. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
Chen JF; Aloyo VJ; Qin ZH; Weiss B
Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
Mavridis M; Besson MJ
Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study.
Augood SJ; Westmore K; Emson PC
Neuroscience; 1997 Feb; 76(3):763-74. PubMed ID: 9135049
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
Arenas E; Alberch J; Marsal J
Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
[TBL] [Abstract][Full Text] [Related]
14. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
15. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity.
Unterwald EM; Cox BM; Kreek MJ; Cote TE; Izenwasser S
Synapse; 1993 Sep; 15(1):33-8. PubMed ID: 8310423
[TBL] [Abstract][Full Text] [Related]
16. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
17. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons.
Lindskog M; Svenningsson P; Fredholm B; Greengard P; Fisone G
Eur J Neurosci; 1999 Jun; 11(6):2182-6. PubMed ID: 10336688
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
[TBL] [Abstract][Full Text] [Related]
19. Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons.
Steiner H; Gerfen CR
Neuroscience; 1999; 88(3):795-810. PubMed ID: 10363818
[TBL] [Abstract][Full Text] [Related]
20. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
